🇺🇸 FDA
Patent

US 10183936

Hepatitis B core protein allosteric modulators

granted A61KA61K31/55A61K31/5513

Quick answer

US patent 10183936 (Hepatitis B core protein allosteric modulators) held by ASSEMBLY BIOSCIENCES, INC. expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ASSEMBLY BIOSCIENCES, INC.
Grant date
Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/55, A61K31/5513, A61K31/553, A61K31/554